U.S. markets open in 1 hour 28 minutes

InMed Pharmaceuticals Inc. (INM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7100+0.0600 (+2.26%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
22.44M26.57M23.03M17.60M32.25M
Enterprise Value 3
13.24M16.82M18.80M12.09M25.56M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.153.505.133.154.75
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-1.71-5.47-10.18-7.87-15.66

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 3-30.99%
S&P500 52-Week Change 335.59%
52 Week High 38.9400
52 Week Low 32.3800
50-Day Moving Average 32.8318
200-Day Moving Average 33.5521

Share Statistics

Avg Vol (3 month) 370.01k
Avg Vol (10 day) 359.27k
Shares Outstanding 58.94M
Implied Shares Outstanding 6N/A
Float 8M
% Held by Insiders 10.86%
% Held by Institutions 16.34%
Shares Short (Jul 14, 2021) 493.35k
Short Ratio (Jul 14, 2021) 41
Short % of Float (Jul 14, 2021) 4N/A
Short % of Shares Outstanding (Jul 14, 2021) 41.04%
Shares Short (prior month Jun 14, 2021) 413.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 05, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:33
Last Split Date 3Jul 05, 2020

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.16%
Return on Equity (ttm)-105.12%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.56M
Net Income Avi to Common (ttm)-9.05M
Diluted EPS (ttm)-1.5050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.45M
Total Cash Per Share (mrq)1.17
Total Debt (mrq)295.05k
Total Debt/Equity (mrq)2.83
Current Ratio (mrq)6.36
Book Value Per Share (mrq)1.29

Cash Flow Statement

Operating Cash Flow (ttm)-9.57M
Levered Free Cash Flow (ttm)-5.77M